GURU.Markets stock price, segment price, and overall market index valuation
The company's share price BioLife Solutions Inc.
BioLife Solutions provides biopreservative media and equipment for the storage and transportation of cells and tissues. Its stock price reflects the growth of the cell and gene therapy industry, which critically depends on the preservation of biological material.
Share prices of companies in the market segment - Dna
BioLife Solutions provides biopreservative media and equipment for the storage and transportation of cells and tissues. We classify it as part of the DNA sector, and the chart below reflects the dynamics of the entire cell and gene therapy industry, which critically depends on its products.
Broad Market Index - GURU.Markets
BioLife Solutions provides biopreservation media and other equipment for the storage and transportation of cells and tissues used in cell therapy. It is a component of the GURU.Markets index. The chart below shows the market. See how the growth of regenerative medicine is impacting BioLife shares.
Change in the price of a company, segment, and market as a whole per day
BLFS - Daily change in the company's share price BioLife Solutions Inc.
Daily fluctuations in BioLife Solutions, a provider of cell and tissue storage media, reflect the state of the cell therapy sector. Change_co reflects sensitivity to client success in biotech. This metric forms the basis for biomanufacturing sector analysis on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Dna
BioLife Solutions, Inc. is a provider of cell and gene therapy tools. This chart highlights the sector's high volatility. Comparing it to BLFS, a key biotech supplier, helps assess its stability.
Daily change in the price of a broad market stock, index - GURU.Markets
BioLife Solutions is a leading provider of cell and tissue preservation and transportation products used in cell and gene therapy. Its business serves as a barometer for the health of the entire biotech industry. The chart below shows the volatility in this sector, helping to assess BioLife's performance.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization BioLife Solutions Inc.
BioLife is a key supplier of biological sample storage and transportation products for the life sciences sector. Its annual growth rate serves as a barometer of R&D investment in the biotech industry. The chart below provides a snapshot of this science-intensive business.
Annual dynamics of market capitalization of the market segment - Dna
BioLife Solutions, Inc. provides critical products for the storage and transportation of cells and tissues used in cell therapy. Its business is the infrastructure foundation for this rapidly growing sector. The chart below shows how its key role and the growth of the gene therapy industry are impacting its growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
BioLife, a supplier of biomaterial preservation tools, is a gold mine in the world of biotechnology. Demand for its products is stable, as cell and gene therapy development continues. The company's stock price has demonstrated the steady growth typical of companies providing scientific infrastructure.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization BioLife Solutions Inc.
The market capitalization of BioLife, a supplier of cell therapy tools, depends on biotech R&D cycles. The monthly fluctuations on the chart reflect demand for its cryopreservation media and other equipment from biotech companies developing cell and gene therapies.
Monthly dynamics of market capitalization of the market segment - Dna
BioLife Solutions, Inc. provides critical tools and services for cell and gene therapy, primarily environments for the storage and transportation of biomaterials. The dynamics of its sector, shown in the graph, reflect the growth of biopharma. Against this backdrop, one can see how its products are becoming the "gold standard" in the supply chain for the medicine of the future.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
BioLife Solutions provides critical products (such as cryopreservation media) for cell and gene therapy. Demand for its products is growing alongside the sector's development. A full-market chart allows us to assess how BioLife shares, like the "shovels and picks" of the biotech revolution, move in sync with sentiment in the healthcare sector.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization BioLife Solutions Inc.
BioLife Solutions, a provider of tools and services for cell and gene therapy (such as biomaterial storage media), whose weekly stock price reflects activity in the biotech sector. R&D spending in this area shapes short-term expectations for this infrastructure player.
Weekly dynamics of market capitalization of the market segment - Dna
BioLife Solutions, as a provider of cell therapy, is a barometer for this biotech segment. The chart compares its performance with the industry, demonstrating how dependent it is on sector-wide trends in R&D spending, which is its primary source of revenue.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
BioLife Solutions supplies critical products (cryopreservatives) to the cell and gene therapy industry. Its business is a barometer of the health of the entire biotech sector. The chart below shows how BLFS shares correlate with biotech indices and the broader market.
Market capitalization of the company, segment and market as a whole
BLFS - Market capitalization of the company BioLife Solutions Inc.
BioLife Solutions' stock price is a financial "refrigeration" for cell and gene therapy. The market cap of this company, which produces media for preserving and transporting living cells, reflects the growth of the entire regenerative medicine industry. Its growth reflects the fact that its products are a critical tool for delivering "living medicines" to patients.
BLFS - Share of the company's market capitalization BioLife Solutions Inc. within the market segment - Dna
BioLife Solutions provides critical tools and services for cell and gene therapy, particularly cryopreservation media. Its market share reflects its indispensable role in this cutting-edge field of medicine. The chart below illustrates how dependent the entire regenerative medicine industry is on BioLife's products.
Market capitalization of the market segment - Dna
BioLife Solutions supplies critical products for the storage and transportation of cells and tissues for cell therapy. The chart below shows the overall market capitalization of the entire biotech sector. Its growth reflects the development of the entire regenerative medicine industry, where BioLife is the "shovel supplier."
Market capitalization of all companies included in a broad market index - GURU.Markets
BioLife Solutions supplies critical media and tools for the storage and transportation of cells and tissues used in cell therapy. Its market capitalization chart tells the story of the "cold chain" for the future of medicine, demonstrating how biopreservation infrastructure is becoming a valuable asset.
Book value capitalization of the company, segment and market as a whole
BLFS - Book value capitalization of the company BioLife Solutions Inc.
BioLife Solutions' book value is derived from its cell storage media production facilities and equipment. The chart below shows the material base for cell therapy. Its growth reflects investments in the production of products that are critical to the entire biopharma industry.
BLFS - Share of the company's book capitalization BioLife Solutions Inc. within the market segment - Dna
BioLife Solutions supplies critical products for cell and gene therapy, primarily biomaterial storage media. Its business requires certified manufacturing facilities. The asset share chart will show the physical infrastructure needed to ensure the safety of future drugs.
Market segment balance sheet capitalization - Dna
BioLife Solutions supplies critical products for cell and gene therapy, specifically media for the storage and transportation of biomaterials. Its business operates at the intersection of science and logistics. The chart below shows how its balance sheet reflects its investments in specialized manufacturing and research and development.
Book value of all companies included in the broad market index - GURU.Markets
BioLife Solutions' assets constitute critical infrastructure for cell and gene therapy. The company's book value reflects its production capacity for cryopreservation media, as well as its fleet of specialized freezers. This is the material base that ensures the safety of living cells from the laboratory to the patient.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - BioLife Solutions Inc.
BioLife Solutions supplies critical products for cell and gene therapy, such as cryopreservation media. Its book value is small, but its market capitalization reflects its status as a "pix and shovel supplier" in the biotech gold rush. Investors value its indispensable role in the drug discovery pipeline.
Market to book capitalization ratio in a market segment - Dna
BioLife Solutions supplies critical products for cell and gene therapy, such as biomaterial storage media. The company's value lies in its technologies and quality standards. The chart shows the market premium placed on its key role in the rapidly growing biopharmaceutical industry, above and beyond the value of its manufacturing facilities.
Market to book capitalization ratio for the market as a whole
BioLife Solutions supplies biopreservative media and equipment for cell and gene therapy. The company's value lies in its products, which are critical to biotech. It's a niche business, where market valuation reflects the uniqueness of the technology rather than its plants. The chart shows the premium the market is willing to pay for infrastructure solutions for the medicine of the future.
Debts of the company, segment and market as a whole
BLFS - Company debts BioLife Solutions Inc.
For BioLife Solutions, a provider of cell and gene therapy tools, debt can be a tool for expanding production capacity and making strategic acquisitions. This chart shows how the company is investing in the production of its cryopreservation media and storage systems, the demand for which is growing alongside the development of the biopharmaceutical industry.
Market segment debts - Dna
BioLife Solutions supplies critical products for cell and gene therapy, such as cryopreservation media. In the biotech instrumentation sector, debt can finance acquisitions to expand product lines and R&D. The chart shows how the company's debt strategy supports its role as a supplier of revolutionary medicine.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio BioLife Solutions Inc.
BioLife Solutions supplies critical products for the storage and transportation of cells and tissues used in cell therapy. Growth in this sector requires investment in production and logistics. This chart shows how the company is financing its expansion. It helps assess whether debt poses risks for a company whose products are key to its customers' success.
Market segment debt to market segment book capitalization - Dna
BioLife Solutions supplies critical products (cryopreservatives, media) for cell and gene therapy. Its products are used at all stages, from research to commercial production. The chart shows the overall debt burden in the biotech sector, helping to assess how this "infrastructure" company is financing its growth amid the therapeutic boom.
Debt to book value of all companies in the market
BioLife Solutions, which supplies critical cell therapy products, is an "infrastructure" company for biotech. This chart shows the overall market debt load. It helps assess how the overall economic situation and the availability of capital for biotech startups (BioLife's clients) affect demand for its products.
P/E of the company, segment and market as a whole
P/E - BioLife Solutions Inc.
BioLife Solutions supplies critical media for the cryopreservation and biopreservation of cells and tissues used in cell therapy. This chart reflects the growth of the regenerative medicine industry. Its high value reflects investors' belief that the company's products will become the "gold standard" for the storage and transportation of living therapeutics.
P/E of the market segment - Dna
BioLife Solutions operates in the cell therapy tools sector. This chart shows the average P/E for this fast-growing niche. A company's P/E is above average, indicating that investors consider its biomaterial preservation products critical and indispensable to the entire regenerative medicine industry, assigning it an "infrastructure" role.
P/E of the market as a whole
BioLife Solutions supplies critical products for the storage and transportation of cells and tissues used in cell and gene therapy. The company is a "shovel supplier" in the biotech gold rush. This chart reflects the mood in the biotech sector. It helps us understand whether BioLife's growth is dependent on the success of individual therapies or is driven by the overall growth of the industry.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company BioLife Solutions Inc.
BioLife Solutions provides biopreservation tools and services for cell and gene therapy, including cryogenic environments and storage. This chart shows expected growth in the regenerative medicine sector. Future profitability depends on the number of clinical trials and commercialization of therapies using the company's products.
%20P%2FE%20BioLife%20Solutions%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-BioLife-Solutions-Inc.&v=1772513412728 "Chart of the company's future (projected) P/E BioLife Solutions Inc.")
Future (projected) P/E of the market segment - Dna
BioLife Solutions supplies critical products for cell and gene therapy, such as cryopreservation media. This chart compares the company's profitability expectations with the life sciences sector. It demonstrates the extent to which investors believe the growth of the biopharmaceutical industry will ensure stable demand for BioLife consumables.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Dna&v=1772513412735 "Future (projected) P/E graph of the market segment - Dna")
Future (projected) P/E of the market as a whole
BioLife Solutions provides biopreservation tools and services, including cell and tissue storage media for cell and gene therapy. Demand for their products is directly dependent on activity in the biotech sector. This chart, showing overall market optimism, reflects investors' willingness to fund R&D, ensuring BioLife a steady flow of orders.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513412739 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit BioLife Solutions Inc.
BioLife Solutions manufactures and supplies biopreservative media and equipment for cell and gene therapy. The company's profits depend on the growth and success of its clients in the biotech and pharmaceutical industries. This chart shows how advances in regenerative medicine and the number of cell therapies performed impact demand for the company's products.
Profit of companies in the market segment - Dna
BioLife Solutions supplies critical biopreservation tools, such as cryopreservation and storage media for cells and tissues. This chart, which shows revenue in the life sciences sector, highlights the growth of cell and gene therapy. BioLife's products are an integral part of the supply chain for these advanced treatments, and their success is directly linked to the growth of the entire industry.
Overall market profit
BioLife Solutions provides critical products for cell and gene therapy, such as cryopreservation media. The company is a "shovel supplier" in the biotech gold rush. Its growth depends not on the success of a single therapy, but on the overall progress of the entire industry, making it a fundamental player in the medicine of the future.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company BioLife Solutions Inc.
BioLife Solutions supplies critical biopreservative media and equipment for cell and gene therapy. Future revenue projections in this chart depend on the growth of the biopharmaceutical industry. Analysts estimate demand for the company's products from developers of new treatments, the success of which determines BioLife's long-term prospects.
%20profit%20of%20the%20company%20BioLife%20Solutions%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-BioLife-Solutions-Inc.&v=1772513412769 "Graph of future (projected) profit of the company BioLife Solutions Inc.")
Future (predicted) profit of companies in the market segment - Dna
BioLife Solutions supplies critical products for cell and gene therapy, such as cryopreservation media. This chart reflects revenue forecasts for the entire biotechnology segment. It helps understand how the business of a company that is a "shovel supplier" in the genetic engineering gold rush compares to overall financial expectations for this cutting-edge industry.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Dna&v=1772513412802 "Graph of future (predicted) profits of companies in a market segment - Dna")
Future (predicted) profit of the market as a whole
BioLife Solutions supplies critical products for the biopreservation of cells and tissues used in cell therapy. Demand for its products is growing alongside the development of regenerative medicine. This chart is important because it reflects the investment climate. During periods of growth, biotech companies, BioLife's clients, find it easier to attract funding for their research.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513412825 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - BioLife Solutions Inc.
BioLife Solutions provides biopreservation tools, such as cell freezing and storage media, for cell and gene therapy. This metric, which correlates market capitalization with revenue, reflects its critical role in the regenerative medicine supply chain. It demonstrates the premium investors are paying for its "shovels and picks" in this rapidly growing industry.
P/S market segment - Dna
BioLife Solutions plays a critical role in cell and gene therapy, supplying biopreservation media and equipment for storing and transporting biological materials. Their products are essential for cell viability. This chart reflects the market premium for revenue in the high-tech consumables sector, demonstrating how investors value BioLife's key role in the drug discovery chain.
P/S of the market as a whole
BioLife Solutions provides biopreservation tools and services for cell and gene therapy, including cryopreservation media and transport solutions. The company plays a critical role in the regenerative medicine supply chain. This chart shows how highly investors value the revenue of a company that provides biotechnology infrastructure.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company BioLife Solutions Inc.
BioLife Solutions supplies biopreservation media and related equipment for cell and gene therapy. This chart illustrates how investors value the company based on its projected revenue. It reflects the market's belief in the exponential growth of the regenerative medicine industry, where the company's products are critical.
%20P%2FS%20BioLife%20Solutions%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-BioLife-Solutions-Inc.&v=1772513412888 "The graph of the company's future (projected) P/S BioLife Solutions Inc.")
Future (projected) P/S of the market segment - Dna
BioLife Solutions provides biopreservation tools and services for cell and gene therapy, including cryopreservation media and transport systems. Its future revenue estimates are reflected here. This high valuation relative to the sector reflects its belief in the exponential growth of the regenerative medicine market, where its products are critical to the entire supply chain.
%20P%2FS%20market%20segment%20graph%20-%20Dna&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Dna&v=1772513412902 "Future (projected) P/S market segment graph - Dna")
Future (projected) P/S of the market as a whole
BioLife Solutions supplies critical products (such as cryopreservation media) for cell and gene therapy. The company's growth is directly tied to the success of the entire biopharmaceutical industry. This graph of overall investor expectations is an indicator of their belief in the future of regenerative medicine and their willingness to invest in the sector's infrastructure.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513412924 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales BioLife Solutions Inc.
BioLife Solutions' revenue is directly linked to the growth of the cell and gene therapy industry. The company sells critical biopreservation media and live cell transport equipment. The growth in this chart reflects the increasing number of clinical trials and commercial launches in the cutting-edge field of regenerative medicine.
Sales of companies in the market segment - Dna
BioLife Solutions supplies critical biopreservation tools and services required for cell and gene therapy. The company's products ensure the safety and viability of biological materials. This chart represents the total revenue of the entire regenerative medicine support technologies market, where BioLife Solutions plays an indispensable role.
Overall market sales
BioLife Solutions, Inc. supplies critical tools and services for cell and gene therapy, such as cryopreservation media. Demand for its products depends on biotech R&D activity. This dynamic, reflecting the overall health of the economy, influences investment in the life sciences sector, which directly determines the number of research programs and clinical trials.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company BioLife Solutions Inc.
BioLife Solutions supplies critical tools and services for cell and gene therapy, such as cryopreservation media. The company's growth is directly linked to the development of the biopharmaceutical industry. This chart reflects analysts' forecasts for the growth of the regenerative medicine market and demand for the company's products from developers of new treatments.
%20sales%20of%20the%20company%20BioLife%20Solutions%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-BioLife-Solutions-Inc.&v=1772513413014 "Schedule of future (projected) sales of the company BioLife Solutions Inc.")
Future (projected) sales of companies in the market segment - Dna
BioLife Solutions supplies instruments and services for cell and gene therapy, primarily cryopreservation media. This chart segments projected sales by product line: biopreservation media, freezers, and logistics services. This shows which part of their ecosystem, according to analysts, will grow the fastest.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Dna&v=1772513413024 "Schedule of future (projected) sales of companies in the market segment - Dna")
Future (projected) sales of the market as a whole
This chart reflects the investment climate in biotech, which is critical for BioLife Solutions. The company supplies tools for cell and gene therapy. Demand for its products depends on research and development activity, funded by venture capital, which inflows increase with economic growth.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513413043 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality BioLife Solutions Inc.
BioLife Solutions plays a critical role in the cell and gene therapy sector, supplying cryopreservation media and other biopreservation equipment. This chart shows how the company's profitability is linked to the growth of biotechnology. Profitability increases with the number of clinical trials and commercialized drugs using its products.
Market segment marginality - Dna
BioLife Solutions provides tools and services for cell and gene therapy, including storage and transport media for biological materials. The company's profitability depends on the growth of the biopharmaceutical industry. This chart shows profitability in related sectors, helping to assess how critical BioLife's products are to the supply chain in this innovative field.
Market marginality as a whole
BioLife Solutions supplies tools and services for cell and gene therapy, such as cryopreservation media. Demand for its products is directly dependent on activity in the biotechnology sector. This chart, reflecting the overall investment climate, shows how actively research and development in advanced medicine is being funded, creating a market for BioLife's products.
Employees in the company, segment and market as a whole
Number of employees in the company BioLife Solutions Inc.
BioLife Solutions provides critical tools and services for cell and gene therapy, such as cryopreservation media. This chart reflects the size of the team supporting this research-intensive business. The growth in the chart reflects the expansion of the regenerative medicine industry and the increasing number of customers using their products for biomaterial preservation.
Share of the company's employees BioLife Solutions Inc. within the market segment - Dna
BioLife Solutions supplies critical tools for cell and gene therapy, including storage and transport media for biomaterials. This chart shows the company's share of the total number of specialists in the biopreservation niche, reflecting its indispensable role in the supply chain for one of the most advanced fields of medicine.
Number of employees in the market segment - Dna
BioLife Solutions, Inc. supplies biopreservation tools and services needed for cell and gene therapy. This chart shows employment trends in the biotechnology sector. The growing number of specialists in this cutting-edge field reflects the rapid advancement of regenerative medicine and the increasing number of clinical trials, driving demand for BioLife products.
Number of employees in the market as a whole
BioLife Solutions supplies critical tools and services for cell and gene therapy, such as cryopreservation media. Their growth is directly linked to advances in biopharmaceuticals. This chart shows the overall economy, but for BioLife, the driver is the number of clinical trials and the commercialization of new treatments, which generate demand.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company BioLife Solutions Inc. (BLFS)
BioLife Solutions supplies cell and gene therapy tools and services, such as cryopreservation media. It is a critical supplier to the biotechnology industry. This reflects the value of their unique products and intellectual property, which are essential for the development of costly, modern treatments.
%20of%20the%20company%20BioLife%20Solutions%20Inc.%20(BLFS)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-BioLife-Solutions-Inc.-BLFS&v=1772513413279 "Chart of market capitalization per employee (in thousands of dollars) of the company BioLife Solutions Inc. (BLFS)")
Market capitalization per employee (in thousands of dollars) in the market segment - Dna
BioLife Solutions supplies critical products (such as cryopreservation media) for cell and gene therapy. They sold shovels during the biotech gold rush. Their value lies in their unique products. This chart shows how the market values their niche biotech support business.
%20by%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Dna&v=1772513413314 "Market capitalization per employee (in thousands of dollars) by market segment - Dna")
Market capitalization per employee (in thousands of dollars) for the overall market
BioLife Solutions supplies critical tools and services for cell and gene therapy, such as cryopreservation media. It is a supplier to the rapidly growing biopharmaceutical industry. Its high employee rating reflects the uniqueness and importance of its products, where a small team creates indispensable components for the entire industry.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513413327 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company BioLife Solutions Inc. (BLFS)
BioLife Solutions provides tools for the cell therapy industry. They produce critical media for cryopreservation and transport of living cells and tissues. This chart demonstrates the profitability of their "pick-and-shovel" model: their high-margin products, essential for R&D, generate significant revenue for a small staff.
%20Chart%20BioLife%20Solutions%20Inc.%20(BLFS)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-BioLife-Solutions-Inc.-BLFS&v=1772513413353 "Company Profit Per Employee (in thousands of dollars) Chart BioLife Solutions Inc. (BLFS)")
Profit per employee (in thousands of dollars) in the market segment - Dna
BioLife Solutions is a "B2B company." They "sell" "critically" "important" "consumables" (media, "cryo" storage) for "cell" and "gene" "therapy." This chart shows the benchmark for the "Biotech" sector (Tools). In this "B2B R&D" sector, the benchmark is *high*. It's a "razor-and-blade" business: profit per employee is generated by "sticky" "consumables."
%20in%20the%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Dna&v=1772513413354 "Chart of profit per employee (in thousands of dollars) in the market segment - Dna")
Profit per employee (in thousands of dollars) for the market as a whole
BioLife Solutions provides critical tools for cell and gene therapy. They produce media for the preservation and transport of living cells (biopreservation). These are "consumables" for biotech. This graph helps us understand the profitability of this niche B2B business, which serves the pharmaceutical industry and requires the highest quality control, per employee.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513413381 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee BioLife Solutions Inc. (BLFS)
BioLife Solutions supplies critical biopreservative media and tools for cell and gene therapy. Revenue per employee reflects the demand for the company's products in the growing biotechnology industry. The graph shows the growth in sales of consumables used at all stages—from research to commercial drug production.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-BioLife-Solutions-Inc.-BLFS&v=1772513413388 "Sales chart per company employee BioLife Solutions Inc. (BLFS)")
Sales per employee in the market segment - Dna
BioLife Solutions supplies critical products for cell and gene therapy. Their flagship product is CryoStor, a medium for freezing and storing live cells. It's a consumable for biotech. This chart shows how efficient their team (production and sales) is. It reflects their ability to sell these high-margin consumables to R&D labs.
Sales per employee for the market as a whole
BioLife Solutions (BLFS) is a "tool supplier" for cell and gene therapy. They produce critical biomaterial preservation media (e.g., CryoStor) and equipment (cryostorage, transport). This graph illustrates their role in the biotech supply chain. Their products (consumables) are essential for every R&D project or cell therapy production. This is a scalable "shovel" model in the biotech gold rush.
Short shares by company, segment and market as a whole
Shares shorted by company BioLife Solutions Inc. (BLFS)
BioLife Solutions provides critical tools for cell and gene therapy: storage and transportation media for biomaterials (cryopreservation) and related equipment. This chart shows the number of bearish bets. Bearish bets may be concerned that slowing funding in the biotech sector will lead to a reduction in R&D and, consequently, demand for BioLife products, or point to intense competition.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-BioLife-Solutions-Inc.-BLFS&v=1772513413434 "Short Shares Chart for the Company BioLife Solutions Inc. (BLFS)")
Shares shorted by market segment - Dna
BioLife Solutions (BLFS) supplies critical products for cell and gene therapy—storage and transportation media for biomaterials (cryopreservation). This chart shows bets against the DNA technology sector. If investors are short this segment, they expect a slowdown in R&D and a reduction in biotech funding, which will reduce the number of clinical trials and demand for consumables.
Shares shorted by the overall market
BioLife Solutions (BLFS) is a biotech company that supplies cell storage media. This Short_All chart shows a risk aversion. This pessimism is drying up venture capital funding for biotechs (BLFS' clients). Ultimately, they have no money left for R&D, which is killing BioLife's main source of income.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator BioLife Solutions Inc. (BLFS)
BioLife Solutions supplies tools and services for cryopreservation and transportation of biomaterials (cell therapy). The business is a "shovel" for biotech. A chart above 70 may reflect a boom in biotech R&D. A range below 30 is often associated with a "venture winter" and concerns about clients cutting R&D budgets.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-BioLife-Solutions-Inc.-BLFS&v=1772513413494 "RSI 14 indicator chart for the company's stock BioLife Solutions Inc. (BLFS)")
RSI 14 Market Segment - Dna
BioLife Solutions provides critical tools and services for cell and gene therapy. The company produces cryopreservation media and biomaterial storage equipment. It is the "infrastructure" for biotech. This graph measures the collective momentum of the biotech equipment (life science tools) sector. It shows whether the entire biotech sector is overheated or whether BLFS has its own drivers.
RSI 14 for the overall market
BioLife Solutions (BLFS) produces media for the storage and transportation of cells and organs. This chart reflects the health of the biotech sector. In a euphoric mood, its clients (biotech companies) are generously funded and conduct R&D, purchasing BLFS consumables. In a panic, their funding dries up, projects are put on hold, and demand falls.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast BLFS (BioLife Solutions Inc.)
BioLife Solutions provides critical tools for cell and gene therapy, primarily cell biopreservation (cryostorage) media. This chart shows the average analyst forecast. Their targets depend on the growth of the cell therapy industry and the demand for consumables from biotech clients.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-BLFS-BioLife-Solutions-Inc.&v=1772513413549 "A chart showing analyst consensus forecasts for the expected stock price. BLFS (BioLife Solutions Inc.)")
The difference between the consensus estimate and the actual stock price BLFS (BioLife Solutions Inc.)
BioLife Solutions (BLFS) is a cell therapy logistics company. They produce cryopreservation media and smart cell transport containers. This chart shows the assessment of their R&D infrastructure. It measures the gap between the price and the consensus target, reflecting the potential analysts see in their role as a biotech supplier.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-BLFS-BioLife-Solutions-Inc.&v=1772513413563 "A chart showing the difference between the consensus forecast and the actual stock price. BLFS (BioLife Solutions Inc.)")
Analyst consensus forecast for stock prices by market segment - Dna
BioLife Solutions is a leading supplier of media and equipment for biopreservation—the preservation of living cells during transport for cell therapy. This chart shows general expectations for the DNA technology sector. It reflects whether experts believe the cell and gene therapy market, which requires complex logistics, will experience rapid growth.
Analysts' consensus forecast for the overall market share price
BioLife Solutions (BLFS) is a logistics company for life. They are the gold standard in cryopreservation (media, freezers) for cell therapy (R&D). This schedule, reflecting expert expectations, affects their clients. If the market is pessimistic, biotech companies (their clients) cut R&D budgets.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index BioLife Solutions Inc.
BioLife Solutions is the spearhead of a revolution in medicine. They provide consumables for cell and gene therapy, including cryo-media (for freezing) and cold logistics solutions. This chart is a barometer of bio-logistics. It likely aggregates R&D spending in biotech, as their products are critical for the preservation and transportation of living cells.
AKIMA Market Segment Index - Dna
BioLife Solutions (BLFS) is the unseen champion in cell therapy, dominating the production of cryopreservation media—the liquids in which living cells (for therapy) are transported and stored. This composite metric evaluates companies. The graph shows the sector average. This benchmark: how does this indispensable role (consumables) (BLFS) differentiate it from the average competitor?
The AKIM Index for the overall market
BioLife Solutions is a provider of biomanufacturing tools and services, specializing in cell preservation (cold chain). It is critical for cell therapy. This chart, reflecting the market average, is a backdrop. It helps assess how BLFS, which is growing alongside the advanced medical sector, compares to the overall macroeconomic picture.
